Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587118 · ClinicalTrials.gov registry record · Phase 4
An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
A Phase 4 study of Post Traumatic Stress Disorder, sponsored by Lori Davis, MD.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01587118: Completed Phase 4 study of Post Traumatic Stress Disorder, sponsored by Lori Davis, MD.
NCT01587118 is a Phase 4 study of Post Traumatic Stress Disorder that has completed, run by Lori Davis, MD. The registered enrollment target is 18 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01587118, a Phase 4 study of Post Traumatic Stress Disorder, has completed, sponsored by Lori Davis, MD.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label pilot study of adjunctive asenapine for the treatment of Posttraumatic Stress Disorder (PTSD) in veterans who have not fully remitted to an adequate trial of standard antidepressant treatment.
Primary Outcome
CAPS is the clinician rating of posttraumatic stress disorder (PTSD) symptoms; higher scores indicate higher severity of PTSD; 17-item score range 0 to 136. Blake DD, Weathers FW, Nagy LM, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 8:75-90.
Conditions Studied
Interventions
- DRUG Adjunctive asenapine
Study Locations (1)
Alabama
- Tuscaloosa VA Medical Center - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-07 |
| Phase | Phase 4 |
What the finished NCT01587118 record still lists
NCT01587118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Adjunctive asenapine is the first listed.
NCT01587118 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT01587118 about?
NCT01587118 is a clinical study titled "An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder". This is an open-label pilot study of adjunctive asenapine for the treatment of Posttraumatic Stress Disorder (PTSD) in veterans who have not fully remitted to an adequate trial of standard antidepressant treatment.
What is the current status of trial NCT01587118?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2012-06. Estimated completion is 2016-07.
What conditions does trial NCT01587118 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT01587118?
The interventions under investigation include: Adjunctive asenapine (DRUG).
Who is sponsoring clinical trial NCT01587118?
This trial is sponsored by Lori Davis, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01587118 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01587118's enrollment target sits among peer trials
18 242nd of 262 higher than 19 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder
RECRUITING · Phase 4
-
An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
RECRUITING · Phase 4
-
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
ACTIVE NOT RECRUITING · Phase 4
-
Short Course Glucocorticoid Treatment for PTSD
COMPLETED · Phase 4
-
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
COMPLETED · Phase 4
-
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia